Author: Thachil, Jecko; Tang, Ning; Gando, Satoshi; Falanga, Anna; Levi, Marcel; Clark, Cary; Iba, Toshiaki; Cattaneo, Marco
Title: Type and dose of heparin in COVID-19. Cord-id: rxgdlfb7 Document date: 2020_4_23
ID: rxgdlfb7
Snippet: We thank the authors for their comments and feedback on the ISTH interim guidance. Hyper-coagulability is indeed a significant issue in COVID-19 and the haemostatic system is shifted markedly towards the procoagulant side in these patients. However, we cannot yet be certain that unfractionated heparin (UFH) is better than low molecular weight heparin (LMWH) in this scenario. Although UFH has been used for several years, it does have practical issues, mainly with respect to the need for frequent
Document: We thank the authors for their comments and feedback on the ISTH interim guidance. Hyper-coagulability is indeed a significant issue in COVID-19 and the haemostatic system is shifted markedly towards the procoagulant side in these patients. However, we cannot yet be certain that unfractionated heparin (UFH) is better than low molecular weight heparin (LMWH) in this scenario. Although UFH has been used for several years, it does have practical issues, mainly with respect to the need for frequent monitoring using the activated partial thromboplastin times (aPTT).
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date